Combination therapy with MDM2 and MEK inhibitors is effective in patient-derived models of lung adenocarcinoma with concurrent oncogenic drivers and MDM2 amplification

Autor:	Arielle Elkrief, Igor Odintsov, Vladimir Markov, Rebecca Caeser, Pawel Sobczuk, Sam E. Tischfield, Umesh Bhanot, Chad M. Vanderbilt, Emily Cheng, Alexander Drilon, Gregory J. Riely, William W. Lockwood, Elisa de Stanchina, Vijaya G. Tirunagaru, Robert C. Doebele, Álvaro Quintanal-Villalonga, Charles M. Rudin, Romel Somwar, Marc Ladanyi
Rok vydání:	2023
Předmět:	Pulmonary and Respiratory Medicine Oncology
Zdroj:	Journal of Thoracic Oncology.
ISSN:	1556-0864
DOI:	10.1016/j.jtho.2023.05.007
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::7bd62fa30f86717037d9c2532683325f https://doi.org/10.1016/j.jtho.2023.05.007 Zobrazit plný text záznamu